Spyre Therapeutics, Inc.
← Back to SYRE Overview

Spyre Therapeutics, Inc. (SYRE)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-45.32

Financial Fundamentals

SYREQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2014-03-31-16.47
2014-06-30-10.45
2014-09-30-7.70
2014-12-31-9.64
2015-03-31-11.87
2015-06-30-20.53
2015-09-30-8.58
2015-12-31-7.00
2016-03-31-6.14
2016-06-30-2.63
2016-09-30-3.42
2016-12-31-2.30
2017-03-31-3.98
2017-06-30-2.05
2017-09-30-2.57
2017-12-31-3.30
2018-03-31-4.94
2018-06-30-5.79
2018-09-30-4.36
2018-12-31-3.13
2019-03-31-3.38
2019-06-30-3.12
2019-09-30-2.93
2019-12-31-2.89
2020-03-31-2.06
2020-06-30-5.72
2020-09-30-6.12
2020-12-31-5.01
2021-03-31-7.13
2021-06-30-16.72
2021-09-30-6.44
2021-12-31-2.87
2022-03-31-1.55
2022-06-30-0.47
2022-09-30-0.68
2022-12-31-0.39
2023-03-31-0.37
2023-06-30-0.05
2023-09-30-0.33
2023-12-31-1.85
2024-03-31-7.70
2024-06-30-7.16
2024-09-30-5.42
2024-12-31-4.86
2025-03-31-5.43
2025-06-30-6.19
2025-09-30-28.07
2025-12-31-45.32

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.